A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection forstage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer ResearchConsortium BTCRC-LUN18-153

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences